Skip to main content
Signal8

Huber Reid M

SEC insider (Form 3/4/5 filer). CIK 0001607052. Director at Rapport Therapeutics, Inc. (RAPP) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in BOSTON, MA.

Companies Huber Reid M has filed insider reports for

  • Rapport Therapeutics, Inc. (RAPP): Director
  • CARGO Therapeutics, Inc. (CRGX): Director
Huber Reid M profile photo

Huber Reid M

CIK: 0001607052

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Rapport Therapeutics, Inc. logo
RAPP

Rapport Therapeutics, Inc.

Director
CARGO Therapeutics, Inc. logo
CRGX

CARGO Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Rapport Therapeutics, Inc. logo
    RAPP

    Rapport Therapeutics, Inc.

    Jun 10, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    15.2K shares-
  • Rapport Therapeutics, Inc. logo
    RAPP

    Rapport Therapeutics, Inc.

    Sep 12, 2025
    Purchase
    Direct
    20.4K shares at avg. $24.48$499K
  • CARGO Therapeutics, Inc. logo
    CRGX

    CARGO Therapeutics, Inc.

    Aug 19, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    25K shares-
  • CARGO Therapeutics, Inc. logo
    CRGX

    CARGO Therapeutics, Inc.

    Jun 18, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    25K shares-
  • Rapport Therapeutics, Inc. logo
    RAPP

    Rapport Therapeutics, Inc.

    Jun 17, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    21.9K shares-

1-5 of 5